Scholarly Works - Journal articles
Journal article
Clin Cancer Res
·
August 3, 2026
PURPOSE: In advanced estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, the combination of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) with endocrine therapy (ET) is the standard of care for tre ...
Full text
Link to item
Cite
Journal article
Mol Cancer Ther
·
April 2, 2026
Endocrine therapy has proven to be beneficial for patients with estrogen receptor (ER)-positive, HER2-negative (ER+/HER2-) breast cancer; however, de novo or acquired resistance remains a major clinical challenge. Upon progression, many of the cancers cont ...
Full text
Link to item
Cite
Journal article
Sci Adv
·
September 27, 2024
Estrogens regulate eosinophilia in asthma and other inflammatory diseases. Further, peripheral eosinophilia and tumor-associated tissue eosinophilia (TATE) predicts a better response to immune checkpoint blockade (ICB) in breast cancer. However, how and if ...
Full text
Open Access
Link to item
Cite
Journal article
Cancer Res
·
September 1, 2023
UNLABELLED: Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term surviv ...
Full text
Open Access
Link to item
Cite
Journal article
BMC cancer
·
June 2018
BackgroundKMT2/MLL proteins are commonly overexpressed or mutated in cancer and have been shown to support cancer maintenance. These proteins are responsible for methylating histone 3 at lysine 4 and promoting transcription and DNA synthesis; howe ...
Full text
Cite